Navigation Links
Melanoma in Medical Technology
... survival rates in patients with metastatic melanoma whose disease had been minimized by other ... interest in developing new therapies for melanoma patients with recurrent or distant metastatic ... for the study. "Patients with metastatic melanoma are at high risk for additional metastases and ...
... immunotherapy is used to treat metastatic melanoma and metastatic renal cell carcinoma, diseases ... States each year, respectively. An increase in melanoma incidence has elevated the disease to the sixth ... 60,000 Americans developed invasive cutaneous melanoma in 2007, with an estimated additional 48,000 or ...
... Offer Hope of First Highly Effective Drug in melanoma Along With Companion Diagnostic BASEL, ... promising treatment for patients with advanced melanoma whose cancer harbours the BRAF mutation (known as ... liver, lung and bone[i]. Historically, metastatic melanoma patients live less than two months before their ...
... only melanoma Immunological effects and clinical outcomes in patients with high-risk melanoma given adjuvant therapy with ... investigator: Lynn Spitler, Northern California melanoma Center, Saint Mary's Medical Center, San ...
... melanoma; other Novartis data on advanced melanoma also presented EAST HANOVER, N.J., May 28 ... age norms on most domains(6). Highlights in melanoma New data highlight the potential of two ... melanoma, the most serious form of skin cancer. melanoma accounts for 41,000 deaths worldwide each ...
... patients with unresectable stage III or stage IV melanoma was stopped early following a planned interim ... these data might have on other ongoing Nexavar melanoma trials. Data from this study are expected to be ... patients with unresectable stage III or stage IV melanoma at more than 200 clinical sites in the United ...
... Results at The Sixth International Symposium on melanoma and Other Cutaneous Malignancies in New York City ... 2 clinical trial for the treatment of metastatic melanoma are as good as or better than Phase 1 data. ... efforts at The Sixth International Symposium on melanoma and Other Cutaneous Malignancies on March 13, ...
... and Professor and Chairman of the Department of melanoma Medical Oncology, at The University of Texas ... to be clinically active against unresectable melanoma in some patients. We look forward to ... providing updated data from the ongoing melanoma and breast cancer studies in the first half of ...
... with pegylated interferon alfa-2b in stage III melanoma patients had a significant and sustained impact ... term pegylated interferon therapy in stage III melanoma had a significant and sustained impact on ... alfa-2b is not approved for treatment of melanoma in either the US or EU. About The Study The ...
... updated CR011-vcMMAE results for the treatment of melanoma by the end of 2008 and the presentation of ... A Phase II study of CR011-vcMMAE in patients with melanoma is currently enrolling patients, and ... the use of CR011-vcMMAE for breast cancer, melanoma and gliomas, and the timeframe of initiating ...
... blood cell, from a 52-year-old man whose Stage 4 melanoma had spread to a groin lymph node and to a lung. T cells specific to targeting the melanoma were then expanded vastly in the laboratory using ... be used for the 25 percent of all late-stage melanoma patients who have the same immune-system type and ...
... -- Results from an adjuvant trial in high-risk melanoma patients demonstrated that a majority of ... may be a potential adjuvant therapy for high-risk melanoma patients," said E. George Elias M.D., Ph.D., Director of Maryland melanoma Center. "The percentage of patients who achieved ...
... "The overexpression of the GPNMB protein by melanoma makes it an intriguing and novel therapeutic ... patients with unresectable Stage III or Stage IV melanoma who have failed no more than one prior line of ... the safety and efficacy in the treatment of melanoma and will enter Phase II during the third quarter ...
... CA. Fifty patients with inoperable Stage IIIc/IV melanoma were enrolled. Patients were given OncoVEX GM-CSF ... in Dallas, TX said: "Patients with advanced melanoma have few current treatment options that produce a ... more than 8,000 people died in the U.S. of melanoma in 2007. Prevalence of Stage III and Stage ...
... immunotherapy as a treatment for metastatic melanoma and non-small cell lung cancer (NSCLC). These ... regarding the use of the genetic profiling of melanoma in predicting clinical outcomes of treatment with MAGE-A3 ASCI. Biopsies performed on the melanoma tumors prior to immunization were used to ...
... analysis showed that stage IV metastatic melanoma patients treated with elesclomol and paclitaxel ... any indication in any market. "The incidence of melanoma has continued to rise in recent years and there ... potentially, other cancer types." Metastatic melanoma occurs ...
... IL on Sunday, June 1 at 9:30am EDT during the melanoma conference session. A summary of the abstract ... more than 8,000 people died in the U.S. of melanoma in 2007. Prevalence of stage III and stage ... Stage IV disease is six months. Treatment of melanoma depends on the stage of the disease with ...
... produces a pronounced reduction of malignant melanoma cell growth. Dermytol(TM), a proprietary ... year. NCI expects more than 8,000 deaths from melanoma and less than 1,000 deaths from non-melanoma ... all of the mice were injected with malignant melanoma tumor cells. Dermytol(TM) or placebo treatments ...
... it shows activity against human tumors including melanoma and is synergistic with alkylating agents ... candidate may offer to patients with malignant melanoma the most serious form of skin cancer." About Metastatic Melanoma Metastatic melanoma is the most deadly form of skin cancer, ...
... updated results from a Phase 2 UVIDEM(R) (IDD-3) melanoma vaccine clinical trial (DC-MEL-202). The updated ... mature dendritic cells loaded with lysates from melanoma tumor cell lines. UVIDEM is produced in IDM ... announced. Thirty-eight patients with malignant melanoma were included in the U.S. Phase 2 study and 53 ...
... with unresectable Stage III or IV malignant melanoma have been treated with CR011-vcMMAE in the Phase ... co-Principal Investigator, Co-Director of the melanoma Program at the Yale Cancer Center in New Haven, ... patients with unresectable Stage III or Stage IV melanoma who have failed no more than one prior line of ...
... immunotherapy is used to treat metastatic melanoma and metastatic renal cell carcinoma, diseases ... States each year, respectively. An increase in melanoma incidence has elevated the disease to the sixth ... 60,000 Americans developed invasive cutaneous melanoma in 2007, with an estimated additional 48,000 or ...
CuraGen Updates CR011-vcMMAE Data at ASCO
... Demonstrated in Advanced Breast Cancer and melanoma - - Conference call to be hosted Wednesday, ... in patients with advanced breast cancer and melanoma at the 2009 Annual Meeting of the American ... trial of CR011-vcMMAE in patients with advanced melanoma were presented at a poster discussion session. ...... Offer Hope of First Highly Effective Drug in melanoma Along With Companion Diagnostic BASEL, ... promising treatment for patients with advanced melanoma whose cancer harbours the BRAF mutation (known as ... liver, lung and bone[i]. Historically, metastatic melanoma patients live less than two months before their ...
... only melanoma Immunological effects and clinical outcomes in patients with high-risk melanoma given adjuvant therapy with ... investigator: Lynn Spitler, Northern California melanoma Center, Saint Mary's Medical Center, San ...
CuraGen to Present CR011-vcMMAE Data at ASCO
... - Update from Advanced Breast Cancer and melanoma Studies - Conference Call to be Hosted on ... in patients with advanced breast cancer and melanoma at the 2009 Annual Meeting of the American ... the safety and efficacy in the treatment of melanoma and for the treatment of metastatic breast ...... melanoma; other Novartis data on advanced melanoma also presented EAST HANOVER, N.J., May 28 ... age norms on most domains(6). Highlights in melanoma New data highlight the potential of two ... melanoma, the most serious form of skin cancer. melanoma accounts for 41,000 deaths worldwide each ...
AlphaVax Announces Promising Results in Melanoma Studies
... melanoma-specific tumor antigens to reduce melanoma tumor burden in a state-of-the-art murine melanoma model. Jedd D. Wolchok, M.D., Ph.D., Lab ... oncologist who specializes in the treatment of melanoma and in whose laboratory the work was conducted. ...Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis
... estimate that nearly one-third of cases of melanoma , the most serious form of skin cancer, are ... their 30s or 40s, coupled with the fact that melanoma is the most common form of cancer for young ... old, more women could be faced with developing melanoma before or during pregnancy. At the recent ...... patients with unresectable stage III or stage IV melanoma was stopped early following a planned interim ... these data might have on other ongoing Nexavar melanoma trials. Data from this study are expected to be ... patients with unresectable stage III or stage IV melanoma at more than 200 clinical sites in the United ...
... Results at The Sixth International Symposium on melanoma and Other Cutaneous Malignancies in New York City ... 2 clinical trial for the treatment of metastatic melanoma are as good as or better than Phase 1 data. ... efforts at The Sixth International Symposium on melanoma and Other Cutaneous Malignancies on March 13, ...
Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
... for the treatment of invasive and metastatic melanoma by the FDA's Office of Orphan ... . About Metastatic melanoma The American Cancer Society has estimated ... of, and approximately 8,400 deaths from, melanoma will occur in 2008 in the United States. ...... and Professor and Chairman of the Department of melanoma Medical Oncology, at The University of Texas ... to be clinically active against unresectable melanoma in some patients. We look forward to ... providing updated data from the ongoing melanoma and breast cancer studies in the first half of ...
Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients
... to high risk and advanced-stage melanoma -- an often fatal form of cancer for which there ... an immune response -- that are commonly found in melanoma tumors. These antigens stimulate T-cells within ... the next cycle of treatment. About Melanoma melanoma is the most serious form of skin cancer, ...CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma
... and Professor and Chairman of the Department of melanoma Medical Oncology at The University of Texas, M.D. ... with CR011-vcMMAE. Completing enrollment in this melanoma study ahead of schedule highlights the external ... Treatment of Patients with Advanced melanoma Type: Oral presentation Presenter: Dr. ...Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology
... investigational anti-CTLA-4 antibody, in melanoma are scheduled to be the subject of presentations ... -- "Efficacy and safety of patients with advanced melanoma treated with ipilimumab with or without the ... in ipilimumab-treated patients with advanced melanoma - results from a Phase 2, ...CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
... - Results from Phase II melanoma Trial Expected in the Fourth Quarter - ... enrollment of patients into the Phase II melanoma trial," commented Dr. Tim Shannon, President and ... we look forward to completing enrollment in the melanoma study and subsequently presenting updated results ...... with pegylated interferon alfa-2b in stage III melanoma patients had a significant and sustained impact ... term pegylated interferon therapy in stage III melanoma had a significant and sustained impact on ... alfa-2b is not approved for treatment of melanoma in either the US or EU. About The Study The ...
... updated CR011-vcMMAE results for the treatment of melanoma by the end of 2008 and the presentation of ... A Phase II study of CR011-vcMMAE in patients with melanoma is currently enrolling patients, and ... the use of CR011-vcMMAE for breast cancer, melanoma and gliomas, and the timeframe of initiating ...
... blood cell, from a 52-year-old man whose Stage 4 melanoma had spread to a groin lymph node and to a lung. T cells specific to targeting the melanoma were then expanded vastly in the laboratory using ... be used for the 25 percent of all late-stage melanoma patients who have the same immune-system type and ...
Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
... ongoing Allovectin-7(R) Phase 3 metastatic melanoma trial. Through a series of cash payments and ... patients with Stage III or IV metastatic melanoma in accordance with a Special Protocol Assessment ... for the treatment of invasive and metastatic melanoma by the FDA's Office of Orphan Products ...CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
... CR011- vcMMAE in patients with advanced melanoma utilizes a Simon 2-Stage design with a primary ... Melanoma The number of people diagnosed with melanoma is rapidly increasing. It is expected that approximately 60,000 new cases of melanoma will be diagnosed and an estimated 8,000 people ...... -- Results from an adjuvant trial in high-risk melanoma patients demonstrated that a majority of ... may be a potential adjuvant therapy for high-risk melanoma patients," said E. George Elias M.D., Ph.D., Director of Maryland melanoma Center. "The percentage of patients who achieved ...
Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center
... trial for the treatment of inoperable metastatic melanoma in the liver using the Company's Percutaneous ... Luke's. Dr. Agarwala, a leader in the field of melanoma and clinical oncology, commented, ... with metastatic ocular and cutaneous melanoma who have unresectable tumors in the liver. The ...... "The overexpression of the GPNMB protein by melanoma makes it an intriguing and novel therapeutic ... patients with unresectable Stage III or Stage IV melanoma who have failed no more than one prior line of ... the safety and efficacy in the treatment of melanoma and will enter Phase II during the third quarter ...
... CA. Fifty patients with inoperable Stage IIIc/IV melanoma were enrolled. Patients were given OncoVEX GM-CSF ... in Dallas, TX said: "Patients with advanced melanoma have few current treatment options that produce a ... more than 8,000 people died in the U.S. of melanoma in 2007. Prevalence of Stage III and Stage ...
... immunotherapy as a treatment for metastatic melanoma and non-small cell lung cancer (NSCLC). These ... regarding the use of the genetic profiling of melanoma in predicting clinical outcomes of treatment with MAGE-A3 ASCI. Biopsies performed on the melanoma tumors prior to immunization were used to ...
Genasense(R) Chemotherapy Program Yields High Response Rate in Patients with Stage 4 Melanoma
... hours. An amendment to the above pilot trial in melanoma is planned that will incorporate this more ... our ongoing Phase 3 AGENDA trial in patients with melanoma and low-normal LDH. We also plan that melanoma will be a target for our development program with ...... analysis showed that stage IV metastatic melanoma patients treated with elesclomol and paclitaxel ... any indication in any market. "The incidence of melanoma has continued to rise in recent years and there ... potentially, other cancer types." Metastatic melanoma occurs ...
... IL on Sunday, June 1 at 9:30am EDT during the melanoma conference session. A summary of the abstract ... more than 8,000 people died in the U.S. of melanoma in 2007. Prevalence of stage III and stage ... Stage IV disease is six months. Treatment of melanoma depends on the stage of the disease with ...
Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
... "Antitumor response and new lesions in advanced melanoma patients on ipilimumab treatment" (Abstract ... -- "Long-term survival of patients with advanced melanoma who received ipilimumab administered at ... and efficacy in patients with advanced melanoma treated with ipilimumab with or without ...Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report
... approved therapies and had refractory metastatic melanoma before receiving Allovectin-7(R). One patient had ... for the treatment of invasive and metastatic melanoma by the FDA's Office of Orphan Products ... of, and approximately 8,400 deaths from, melanoma will occur in 2008 in the United States. ...CuraGen Advances CR011-vcMMAE into Phase II
... for advanced melanoma - - Preliminary Phase I/II results to be ... Professor and Chairman of the Department of melanoma Medical Oncology at M.D. Anderson Cancer Center, ... Melanoma The number of people diagnosed with melanoma is rapidly increasing. It is expected that ...... produces a pronounced reduction of malignant melanoma cell growth. Dermytol(TM), a proprietary ... year. NCI expects more than 8,000 deaths from melanoma and less than 1,000 deaths from non-melanoma ... all of the mice were injected with malignant melanoma tumor cells. Dermytol(TM) or placebo treatments ...
Medarex Announces Ipilimumab Program Continues to Move Forward
... (study 024) for front- line treatment of advanced melanoma is different in design from the Pfizer trial, and ... patients with previously untreated metastatic melanoma (front-line). Ipilimumab is administered at 10 ... . About Advanced Melanoma melanoma is a form of skin cancer characterized by the ...... it shows activity against human tumors including melanoma and is synergistic with alkylating agents ... candidate may offer to patients with malignant melanoma the most serious form of skin cancer." About Metastatic Melanoma Metastatic melanoma is the most deadly form of skin cancer, ...
Researchers Train the Immune System to Deliver Virus That Destroys Cancer in Lab Models
... -- Two days after treatment, the presence of melanoma tumor cells in lymph nodes was significantly ... both the lymph nodes and spleen were free of melanoma tumor cells. -- Mice treated with a single ... developed a potent T-cell response against melanoma tumor cells. -- Although the procedure was ...... updated results from a Phase 2 UVIDEM(R) (IDD-3) melanoma vaccine clinical trial (DC-MEL-202). The updated ... mature dendritic cells loaded with lysates from melanoma tumor cell lines. UVIDEM is produced in IDM ... announced. Thirty-eight patients with malignant melanoma were included in the U.S. Phase 2 study and 53 ...
... with unresectable Stage III or IV malignant melanoma have been treated with CR011-vcMMAE in the Phase ... co-Principal Investigator, Co-Director of the melanoma Program at the Yale Cancer Center in New Haven, ... patients with unresectable Stage III or Stage IV melanoma who have failed no more than one prior line of ...
Recipient of Melanoma Drug in Development Celebrates Two Cancer-Free Years
... to treat forms of cancer. "Mr. Hora had multiple melanoma reoccurrences in the previously treated area of ... being investigated by Provectus for treatment of melanoma and other focal forms of cancer. "When it is ... 2 trial will treat up to eighty Stage III/IV melanoma patients at seven or more sites in Australia and ...Other ContentsOther Tags
(Date:5/17/2013)... Sustainable Global Logistics Operations) is aiming to cut CO2 ... intermodal loading systems and the boosting of intelligent systems ... with experience in the logistics sector and in supply ... a duration of three and a half years. , ... components and ontologies shared by the users, objects and ...
(Date:5/16/2013)... Illustrating a commitment to the support of underrepresented ... Research Foundation has announced the inaugural AGA Investing ... Supported by the National Institute of Diabetes and ... helps underrepresented minority students to further their research ... "By establishing this new award, AGA demonstrates its ...
(Date:5/16/2013)... For decades, scientists have used ancient shorelines to predict the ... Markings of a high shoreline from three million years ago, ... period were thought to be evidence of a high ... This assumption has led many scientists to think that if ... they may do just the same in our modern, progressively ...
Breaking Biology News(10 mins):New logistics services that will cut energy consumption and CO2 emissions 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2World's biggest ice sheets likely more stable than previously believed 2(Date:5/18/2013)... (PRWEB) May 18, 2013 After working diligently ... SizeItUp formally announced the integration of the fitment ... Hyundai Genesis is set to stun the automobile market with ... 2012 Hyundai Genesis is marked as the latest entry in ... the vehicles lined up for the year 2013. , ...
(Date:5/18/2013)... KY (PRWEB) May 18, 2013 During ... hearing loss should consider the legal protections they have, ... when problems arise with their child’s treatment or hearing ... , Since 1927, the American Speech-Language-Hearing Association has used ... disorders and to promote treatment, such as cochlear implants, ...
(Date:5/18/2013)... 6Webs.com is the leader in ... and comprehensive comparisons make 6Webs.com the useful resource consumers ... just recently finished conducting their assessments of the leading ... from 6Webs.com reports, "There has been an increase interest ... of use, expandability and mobility. Combine these features with ...
(Date:5/18/2013)... The California College of Ayurveda Spa is ... Ayurvedic Spa , the client receives stress relief therapies ... lifestyle recommendations and stress management techniques by a Clinical ... traditional healthcare system of India. It is based on ... basis for all optimum health. Ayurveda believes that where ...
(Date:5/18/2013)... Dr. Robert Tracey, an area leader in ... his knowledge of the root causes of sleep apnea to ... being Better Sleep Month, Dr. Tracey points out estimates revealing ... disorder, and sleep apnea is one of the most common ... essentially stop breathing at different times while sleeping. When this ...
Breaking Medicine News(10 mins):Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Best Wireless Home Security System Companies Released by 6Webs.com 2Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3[0] Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis[0] Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights[0] Best Wireless Home Security System Companies Released by 6Webs.com[0] Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center[0] Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month
IrishDataPodCustomersDividingReferendumBloomingFacingLogicalisAshcroftGuildMeriterWattsExpetecDepartment
Other Tags| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |